Aug 13, 02:05 AM

CSL Ltd Shares Fall Over 3% on Profit Forecast Below Expectations

Shares of CSL Ltd fell more than 3% on Tuesday after the Australian biotech firm forecast an annual profit that was higher than a year earlier but below market consensus. This decline comes despite CSL Ltd highlighting strength in its immunoglobulin sector, which has shown potential in the $12 billion US market.

#CSL Ltd #Australian

Written with ChatGPT (GPT-4o).

Sources

Reuters Health@Reuters_Health
1 year ago
Shares of CSL Ltd fell more than 3% on Tuesday after the Australian biotech firm forecast an annual profit that was higher than a year earlier but below market consensus. https://t.co/lCJvxUbIYi https://t.co/lCJvxUbIYi
Bull Bear Bres|nahan@BullBearBres
1 year ago
$CSL.AU | $CSLLY 🇦🇺 CSL Release/ Report https://t.co/gaScekqF6c https://t.co/HgdxGfQXXG Presentation https://t.co/QAPivVMNRJ Webcast https://t.co/fjirOgyhls https://t.co/vasYfOLjI4
Reuters@Reuters
1 year ago
Australia's CSL falls on weaker-than-expected annual profit forecast https://t.co/pJlrYBe8Hn https://t.co/NljkjMy36L

CSL Ltd Shares Fall Over 3% on Profit Forecast Below Expectations

Sources

Additional media

Similar Stories